{"id":8162,"date":"2022-03-16T16:18:53","date_gmt":"2022-03-16T16:18:53","guid":{"rendered":"https:\/\/live-cancer-factfinder.pantheonsite.io\/fact-finder-tool\/obezite\/"},"modified":"2026-10-20T17:04:35","modified_gmt":"2026-10-20T17:04:35","slug":"obezite","status":"publish","type":"post","link":"https:\/\/cancerfactfinder.org\/ht\/zouti-pou-cheche-enfomasyon\/obezite\/","title":{"rendered":"AFIKASYON: Obezite lak\u00f2z kans\u00e8"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Sa ou ka tande<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Obezite te lye ak div\u00e8s kalite kans\u00e8.<\/span><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"what-science-tells-us\">Sa syans di nou<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Obezite oubyen yon endis mas k\u00f2por\u00e8l (IMC) ki wo se yon kondisyon kote yon moun gen yon kantite ak\/oswa yon distribisyon gr\u00e8s nan k\u00f2 li ki pa bon pou sante li. Pou mezire obezite, ch\u00e8ch\u00e8 yo souvan itilize ech\u00e8l IMC a, ki det\u00e8mine l\u00e8 yo divize pwa yon moun (an kilogram) pa wot\u00e8 li (an m\u00e8t) kare. IMC a bay yon mezi obezite ki pi egzak pase pwa poukont li, byenke li gen limit li yo. Pr\u00e8ske 70% nan granmoun ameriken yo gen yon IMC 25.0 oswa plis, ki karakterize k\u00f2m tw\u00f2 gwo (25.0-29.9) oswa ob\u00e8z (30.0 ak plis) (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">). Sepandan, gen anpil mezi obezite, epi chak nan sa yo ka asosye av\u00e8k diferan risk kans\u00e8.<\/span><\/p>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Epidemyolojik<\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Gen pr\u00e8v konsistan ki montre ke yon pi gwo kantite gr\u00e8s nan k\u00f2 a lye av\u00e8k yon kantite kans\u00e8. Moun ki gen obezite gen enflamasyon kwonik, ki, av\u00e8k tan, ka lak\u00f2z domaj ADN ki mennen nan kans\u00e8. Moun sa yo gen plis chans tou pou yo gen kondisyon oswa maladi ki lye av\u00e8k oswa ki lak\u00f2z enflamasyon kwonik: pa egzanp, \u00e8zofaj Barrett, w\u00f2ch nan biliy\u00e8, kolit ils\u00e8ratif, ak epatit (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">). Kans\u00e8 ki lye av\u00e8k obezite yo enkli:<\/span><\/p>\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Andometriyal: Fanm ob\u00e8z ak ki gen tw\u00f2p pwa gen 2 a 4 fwa plis chans pase fanm ki gen yon BMI ki an sante pou yo devlope kans\u00e8 andometriyal (kans\u00e8 nan pawa matris la). Risk pou kans\u00e8 andometriyal ogmante l\u00e8 w ap pran pwa nan laj adilt (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">\u00c8zofaj: Moun ki gen tw\u00f2p pwa oswa ob\u00e8z gen 2 fwa plis chans pase moun ki gen yon BMI ki an sante pou yo devlope adenokasin\u00f2m \u00e8zofaj (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kardya gastrik: Moun ki ob\u00e8z gen pr\u00e8ske de fwa plis chans pase moun ki gen yon pwa ki an sante pou yo devlope kans\u00e8 nan pati sipery\u00e8 vant lan, ki pi pre \u00e8zofaj la (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Fwa: Moun ki gen tw\u00f2p pwa oswa ob\u00e8z gen jiska de fwa plis chans pase moun ki gen yon pwa ki an sante pou yo devlope kans\u00e8 nan fwa; asosyasyon sa a pi f\u00f2 nan gason (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ren: Moun ki gen tw\u00f2p pwa oswa ob\u00e8z gen jiska de fwa plis chans pase moun ki gen yon pwa ki an sante pou yo devlope kans\u00e8 selil ren, f\u00f2m kans\u00e8 ren ki pi komen (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Myel\u00f2m miltip: Myel\u00f2m miltip se yon kans\u00e8 ki f\u00f2me nan yon kalite espesifik globil blan (selil plasma) epi ki akimile nan mw\u00e8l zo a. Konpare ak moun ki gen yon pwa ki an sante, moun ki tw\u00f2 gwo oswa ob\u00e8z yo gen yon ogmantasyon 10-20% nan risk pou yo devlope myel\u00f2m miltip (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Menenjy\u00f2m: Yon menenjy\u00f2m se yon tim\u00e8 ki grandi dousman epi ki devlope nan manbr\u00e0n ki antoure s\u00e8vo a ak mwal epiny\u00e8 a. Risk pou gen menenjy\u00f2m ogmante pa 50% nan moun ki ob\u00e8z e 20% nan moun ki tw\u00f2 gwo. <\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Pankreyas: Moun ki gen tw\u00f2p pwa oswa ob\u00e8z gen apepr\u00e8 1.5 fwa plis chans pou yo devlope kans\u00e8 nan pankreyas (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Kolorektal: Moun ki ob\u00e8z gen 30% plis chans pou yo devlope kans\u00e8 kolorektal pase moun ki gen yon pwa ki an sante (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Vezikil biliy\u00e8: Moun ki ob\u00e8z gen yon ogmantasyon 60% nan risk pou yo gen kans\u00e8 nan vezikil biliy\u00e8 (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tete: Fanm ki nan menopoz ki ob\u00e8z gen yon ogmantasyon 20-40% nan risk pou yo devlope kans\u00e8 nan tete (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Ov\u00e8: Yon IMC ki pi wo asosye av\u00e8k yon ogmantasyon 10% nan risk kans\u00e8 nan ov\u00e8 pami fanm ki pa janm itilize terapi ormon menopoz (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiwoyid: Yon IMC ki pi wo asosye av\u00e8k yon ogmantasyon 10% nan risk kans\u00e8 tiwoyid nan mitan fanm ki pa janm itilize terapi ormon menopoz (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">).<\/span><\/li>\n<\/ul>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Kay moun ki dyagnostike ak kans\u00e8 nan tete, pwostat, oswa kolorektal, rech\u00e8ch montre ke obezite ka agrave asp\u00e8 sivivans kans\u00e8 a (pa egzanp: kalite lavi, repetisyon kans\u00e8, pwogresyon kans\u00e8, ak siviv).<\/span><\/p>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Laboratwa\/Pr\u00e8v Sip\u00f2<\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Anjeneral, pr\u00e8v etid laboratwa ak sou b\u00e8t yo sip\u00f2te pr\u00e8v epidemyolojik ki montre obezite asosye av\u00e8k risk pou plizy\u00e8 kalite kans\u00e8.  <\/span><\/p>\n\n<h3 class=\"wp-block-heading\">Klasifikasyon kanseroj\u00e8n IARC:<span style=\"font-weight: 400;\"> <\/span><\/h3>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Pa klase<\/span> .<\/p>\n\n<h2 class=\"wp-block-heading\" id=\"how-to-reduce-your-risk\">Kijan pou diminye risk ou<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Etid epidemyolojik yo bay pr\u00e8v konsistan ki montre moun ki gen yon BMI ki an sante gen mwens risk pou yo gen kans\u00e8 nan kolon, ren, tete, andometryal, ak ov\u00e8 (<\/span> <a href=\"https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">NCI<\/span><\/a> <span style=\"font-weight: 400;\">). Etid yo montre ke moun ki p\u00e8di pwa gen mwens risk pou yo gen kans\u00e8 nan tete, andometryal, kolon, ak pwostat. Moun ki gen obezite ki sibi operasyon baryatrik yo sanble gen mwens risk pou yo gen kans\u00e8 ki gen rap\u00f2 ak obezite pase moun ki pa sibi operasyon baryatrik.<\/span><\/p>\n\n<p class=\"wp-block-paragraph\"><br\/><span style=\"font-weight: 400;\">Etap pou anpeche pran pwa san sante yo se menm ak etap pou p\u00e8di pwa: f\u00e8 egz\u00e8sis regily\u00e8man, kenbe yon rejim alimant\u00e8 ki an sante, epi kontwole pwa ou. Pou anpeche pran pwa, yo rek\u00f2mande 150-300 minit aktivite entansite modere pa sem\u00e8n (<\/span> <a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/obesity\/symptoms-causes\/syc-20375742\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Mayo Clinic<\/span><\/a> <span style=\"font-weight: 400;\">). Yon rejim alimant\u00e8 ki an sante gen ladan manje ki ba nan kalori ak ki rich an eleman nitritif (tankou fwi, legim, ak grenn antye), evite gr\u00e8s satire, epi limite bagay dous, alk\u00f2l, ak manje trete. Idantifye sitiyasyon ki deklanche tw\u00f2p manje epi kontwole sitiyasyon sa yo kapab anpeche pran pwa tou. Finalman, konsistans nan rejim alimant\u00e8 ak egz\u00e8sis, epi kontwole pwa ou regily\u00e8man ka ede kenbe pwa anplis yo.<\/span><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"bottom-line\">Liy final la<\/h2>\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Obezite ogmante risk pou kans\u00e8 andometriyal, \u00e8zofaj, kadyak gastrik, fwa, ren, myel\u00f2m miltip, menenjy\u00f2m, kans\u00e8 pankreyas, kolorektal, vezikil biliy\u00e8, tete, ov\u00e8 ak tiwoyid. Etap pou anpeche pran pwa malsen yo se menm ak etap pou p\u00e8di pwa: F\u00e8 egz\u00e8sis regily\u00e8man, kenbe yon rejim alimant\u00e8 ki an sante epi kontwole pwa ou. <\/span><\/p>\n\n<h2 class=\"wp-block-heading\" id=\"sources-and-links-for-more-inf\">Aprann plis nan sous sa yo ou ka f\u00e8 konfyans<\/h2>\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"How does obesity cause cancer?\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/kIxiI9eiAgk?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Obesity and Cancer: What You Need To Know\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/N6AR0lBwrNM?start=86&#038;feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n<h2 class=\"wp-block-heading\" id=\"date\"><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Sa ou ka tande Obezite te lye ak div\u00e8s kalite kans\u00e8. Sa syans di nou Obezite oubyen yon endis mas k\u00f2por\u00e8l (IMC) ki wo se yon kondisyon kote yon moun gen yon kantite ak\/oswa yon distribisyon gr\u00e8s nan k\u00f2 li ki pa bon pou sante li. Pou mezire obezite, ch\u00e8ch\u00e8 yo souvan itilize ech\u00e8l IMC&hellip;<\/p>\n","protected":false},"author":1,"featured_media":8163,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[545,471],"tags":[472],"class_list":["post-8162","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-rejim-alimante-ak-nitrisyon","category-stil-lavi","tag-definitivman-oswa-pwobableman-vre"],"acf":[],"_links":{"self":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/comments?post=8162"}],"version-history":[{"count":9,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8162\/revisions"}],"predecessor-version":[{"id":18147,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/8162\/revisions\/18147"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media\/8163"}],"wp:attachment":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media?parent=8162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/categories?post=8162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/tags?post=8162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}